Stanley Cohen

Hodges, Nakagawa receive Cohen Innovation funds

Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds

The elusive Nobel Prize winner

Stanley Cohen wanted to be left alone to do his research. I wanted to interview him for a radio show. Amazingly, he said yes.

Nobel Prize-winning biochemist Stanley Cohen dies at 97

Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.

Call for applications: 2017 Stanley Cohen Innovation Fund

The Vanderbilt University School of Medicine is now soliciting applications for research awards from the Stanley Cohen Innovation Fund.

New fund honors spirit of Cohen’s innovative research

When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).

VU study identifies new mechanism for cancer development

Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.